Rating History for Aratana Therapeutics (PETX) by Credit Suisse

More Stocks Rated by Credit Suisse | Latest Ratings for PETX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/30/2019 Erin Wright Downgrade Neutral
(Outperform)		 N/A
(N/A)		 4.79
(4.92)		 2.71% Details